Telemus Capital, LLC Ab Cellera Biologics Inc. Transaction History

Telemus Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 27, 2021	SELL	$14.85 - $21.34 $198,990 - $285,956	-13,400 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$20.19 - $34.17 $207,957 - $351,951	-10,300 Reduced 43.46%	13,400 $295,000
Q1 2021 Apr 20, 2021	BUY	$23.29 - $53.2 $365,653 - $835,240	15,700 Added 196.25%	23,700 $666,000
Q4 2020 Jan 28, 2021	BUY	$39.0 - $58.9 $312,000 - $471,200	8,000 New	8,000 $322,000

155

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $833M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Telemus Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Telemus Capital, LLC with notifications on news.